Griffin M R, Ray W A, Mortimer E A, Fenichel G M, Schaffner W
Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2637.
Pediatrics. 1991 Nov;88(5):881-5.
To evaluate the risks of seizures and other neurologic events following measles-mumps-rubella (MMR) or measles-rubella (MR) immunization, a retrospective cohort study was conducted among 18,364 Tennessee children enrolled in Medicaid who received MMR or MR immunizations in their first 3 years of life. One hundred children had seizures at some time between immunization and 36 months; there were no encephalopathies during this period. Four children had febrile seizures in the 7 through 14 days following MMR or MR immunization compared with 72 in the interval 30 or more days following MMR or MR immunization yielding a relative risk (95% confidence interval) of 2.1 (0.7 to 6.4). Although not statistically significant, this increase in febrile seizures in the 7- through 14-day interval following MMR immunization is coincident with the occurrence of fever following MMR immunization and is consistent with reports of other investigators.
为评估麻疹-腮腺炎-风疹(MMR)或麻疹-风疹(MR)疫苗接种后癫痫发作及其他神经系统事件的风险,我们对田纳西州18364名参加医疗补助计划、在生命最初3年内接种过MMR或MR疫苗的儿童进行了一项回顾性队列研究。100名儿童在接种疫苗后至36个月期间的某个时间出现了癫痫发作;在此期间无脑病发生。4名儿童在接种MMR或MR疫苗后7至14天出现热性惊厥,而在接种MMR或MR疫苗30天或更长时间间隔内有72名儿童出现热性惊厥,相对风险(95%置信区间)为2.1(0.7至6.4)。尽管无统计学显著性,但MMR疫苗接种后7至14天间隔内热性惊厥的这种增加与MMR疫苗接种后发热的发生同时出现,并且与其他研究者的报告一致。